Adagene
Adagene is an antibody discovery and engineering company which seeks to establish technology-driven discovery partnerships.
loading funding rounds…
Sequoia(exited)
King Star Capital(exited)
Gopher Asset Management(exited)
AVIC Trust(exited)
New World TMT(exited)
F-Prime(exited)
WuXi Healthcare Ventures(exited)
GP Healthcare Capital(exited)
Eight Roads Ventures(exited)
General Atlantic(exited)
HongShan(exited)
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (68 %) | - | 2020 % | (9 %) | 95 % | (99 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (944 %) | (3481 %) | (3651 %) | (693 %) | (876 %) | (90 %) | (29790 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (1010 %) | (3423 %) | (3423 %) | (719 %) | (861 %) | (105 %) | (32386 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 1064 % | 3377 % | 3377 % | 669 % | 875 % | 202 % | 27888 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.